- to investigate the additional value of a pharmaceutical consultant at the cardiology outpatient unit on qualtiy, safety, efficacy, patient's satisfaction and costs compared to usual care.Usual care (a normal cardiologist's consultation)…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
begrip medicatie die wordt gebruikt
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Discrepancies between new or dosage-adapted prescriptions (phase 1) and what
the patient really is using (phase 2).
Discrepancies are determined during phase 2 based on information goven by the
patient and information from CardioNL (archive cardiology) and OZIS (history of
pharmacy deliveries).
Secondary outcome
- time of consult cardiologist + time for making medication overview by
cardiologist
- patient's satisfaction
- number of pharmacotherapeutic advices by pharmaceutical consultant
- acute hospital admissions between consult 1 and 2
Background summary
*To Err Is History*
From the well-known report To err is human, it is known that many errors in
health care involves medication[1].
In The Netherlands it was found that medication problems are related to a large
amount of hospital admissions [2-3]. One of the problems with medication is
lack of medication overview when patient are transfered from home setting to
the hospital [4-5] and lack of medication insight by patients.
Local research: Atrium MC
In previous observational (pilot) research it was found that many medication
transfer errors occurred in the outpatients clinic * in 120 patients more than
150 medication discrepancies occurred compared to medication history from
pharmacies or lack of follow-up of medication changes by cardiologists [6].
It is necessary to make a good overview of the medication that patients use for
the doctor to make treatment decisions and to prevent introducing transfer
errors in prescriptions. Moreover, it is important that patient which
medication they use and in which dosage.
Various research has been done on this tiopic in The Netherlands for hospital
admissions [7-13]. For outpatients clinical consults there is still a lack of
data.
Intervention research: CHARM
After finishing the pilot research project, we will investigate the potential
role of the pharmaceutical consultant to make a medication overview with the
outpatient for the doctor, and checking the knowledge of the patient's
medication usage.
CHARM: pharmaceutical Consultant Helpts in outpatient cardiology unit Atrium
hospital in Reconciliation of Medication.
Medication reconciliation: verification, clarification, reconciliation and
transmission.
REFERENTIES
1. Kohn LT, Corrigan JM, Donaldson MS, red. To err is human.Washington DC:
National Academy Press; 1999.
2. Van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reactionrelated
hospitalisations: a population-based cohort study. Pharmacol Drug Safety
2008;17(4):365-71.
3. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors
for preventable medication-related hospital admissions in the Netherlands. Arch
Int Med 2008;168(17):1890-6.
4. Conceptrichtlijn Overdracht van medicatiegegevens 2008. Utrecht: Inspectie
voor de gezondheidszorg; 2008.
www.medicatieoverdracht.nl/uploaddb/downl_object.asp?atoom=9008&VolgNr=1.
5. Medicatieverificatie bij opname en ontslag. Veiligheidsprogramma VMS Zorg;
2008. http://vmszorg.nl/Documents/Tools_Extras/Thema*s/
Medicatieverificatie/20080101_praktijkgids_medverificatie.pdf.
6. Munnecom MPM, Slikkerveer M, Kragten JA, Groothuis S, Krings AWH.
Medicatieoverzicht openbare apotheken als gouden standaard. Pilotonderzoek naar
medicatiefouten op een polikliniek cardiologie. Pharm Weekbl 2005;912-5.
7. R.N. Eggink, A.W. Lenderink, J.W.M.G. Widdershoven en P.M.L.A. van den Bemt.
Begeleiding bij ontslag van hartfalen patienten. Pharm Weekbl Wetenschappelijk
Platform 2009;3(5):89-92
8. M.E.P. Jansen, S. van Zelst, E. van Eijkern, M.R. Ramrattan, L. Lie-A-Huen
en P.N. Langendijk. Bijdrage farmaceutisch opnamegesprek door
apothekersassistent aan preventie van transmurale medicatiefouten. Pharm Weekbl
Wetenschappelijk Platform. 2008;2(6):127-131
9. Duyvendak M, Bosman J, Klopotowska J, Kuiper-Herder AJ, Roon EN van,
Brouwers JRBJ. Perioperatief geneesmiddelmanagement. Reductie van
geneesmiddelgerelateerde problemen door participatie van de ziekenhuisapotheker
in het (pre)klinisch traject bij patiënten met een electieve orthopedische
ingreep. Pharm Weekbl Wetenschappelijk Platform. 2007;1(5):105-109
10. D.A. Appelo, I.E.J. Berger-De Jong en M.J.A. Janssen. Effect van
preoperatieve farmacotherapeutische opnamegesprekken op de kwaliteit van het
medicatieoverzicht op een orthopedische afdeling. Pharm Weekbl Wetenschappelijk
Platform. 2008;2(1):8-13
11. Berlo-van de Laar IRF van. Opnamegesprekken verminderen fouten. Rol voor
Apotheek Service Punt bij veiligheidsmanagement. Pharm Weekbl 2008;15.
12. van Berlo-van de Laar IRF. Ruim 10% fouten bij opname en ontslag. Evaluatie
van de transmurale informatie-overdracht na interventie Steunpunt Apotheken.
Pharm Weekbl. 2004;139:974-7.
13. Ros JJW, Van der Steege Y. De apothekersassistent doet het beter.
Meerwaarde bij medicatieopname- en -ontslaggesprek Pharm Weekbl 2010:18-21.
Study objective
- to investigate the additional value of a pharmaceutical consultant at the
cardiology outpatient unit on qualtiy, safety, efficacy, patient's satisfaction
and costs compared to usual care.
Usual care (a normal cardiologist's consultation) means an interview of 10
minutes by the cardiologist, in which a medication overview is made based on
information of the patient, and usually treatment decisions are made with new
or recurrent prescriptions.
Study design
Randomised (1:1) open trial
Intervention
Medication reconciliation and guidance by pharmaceutical begeleiding door
farmaceutisch consulent
Study burden and risks
Not applicable.
Henri Dunantstraat 5
6419 PC
NL
Henri Dunantstraat 5
6419 PC
NL
Listed location countries
Age
Inclusion criteria
Age 65 years or older;
At least 5 drugs prescribed
Exclusion criteria
-
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL32653.096.10 |